Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23,456 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Langerhans Cells Directly Interact with Resident T Cells in the Human Epidermis.
Oka T, Hasegawa T, Lee T, Oliver-Garcia VS, Mortaja M, Azin M, Horiba S, Smith SS, Khattab S, Trerice KE, Chen ST, Semenov YR, Demehri S. Oka T, et al. Among authors: lee t. JID Innov. 2024 Nov 7;5(1):100324. doi: 10.1016/j.xjidi.2024.100324. eCollection 2025 Jan. JID Innov. 2024. PMID: 39803386 Free PMC article.
Challenges and potential solutions to enrollment in a clinical trial of arteriovenous fistula vs arteriovenous graft vascular access strategy.
Goldman MP, Patel DM, Chang KZ, Davis RP, Edwards MS, Hurie JB, Sutsrim A, Velazquez-Ramirez G, Williams TK, Grandas OH, Freeman MB, McNally MM, Stevens SL, Bennett KM, Woo K, Carsten CG, Androes MP, Blas JV, Jones B, Patton RM, Parr R, Gandhi SS, York JW, Young CJ, Rabbani MU, Gardezi AI, Abdelnour LM, Lee T, Abusalah WM, Zayas CF, Hicks CW, Geetha D, Brown WM, Chen H, Allon M, Murea M; AV Access Consortium. Goldman MP, et al. Among authors: lee t. JVS Vasc Insights. 2024;2:100108. doi: 10.1016/j.jvsvi.2024.100108. Epub 2024 Jun 7. JVS Vasc Insights. 2024. PMID: 39802461 Free PMC article.
Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study.
Sangro B, Kudo M, Erinjeri JP, Qin S, Ren Z, Chan SL, Arai Y, Heo J, Mai A, Escobar J, Lopez Chuken YA, Yoon JH, Tak WY, Breder VV, Suttichaimongkol T, Bouattour M, Lin SM, Peron JM, Nguyen QT, Yan L, Chiu CF, Santos FA, Veluvolu A, Thungappa SC, Matos M, Żotkiewicz M, Udoye SI, Kurland JF, Cohen GJ, Lencioni R; EMERALD-1 Investigators. Sangro B, et al. Lancet. 2025 Jan 8:S0140-6736(24)02551-0. doi: 10.1016/S0140-6736(24)02551-0. Online ahead of print. Lancet. 2025. PMID: 39798579
23,456 results
You have reached the last available page of results. Please see the User Guide for more information.